References
- Seethala RR, Stenman G. Update from the 4th edition of the world health organization classification of head and neck tumours: tumors of the salivary gland. Head Neck Pathol. 2017;11(1):55–67. doi:https://doi.org/10.1007/s12105-017-0795-0
- de Sá Alves M, de Sá Rodrigues N, Bandeira CM, Chagas JFS, Pascoal MBN, Nepomuceno GLJT, da Silva Martinho H, Alves MGO, Mendes MA, Dias M, et al. Identification of possible salivary metabolic biomarkers and altered metabolic pathways in South American patients diagnosed with oral squamous cell carcinoma. Metabolites. 2021;11(10):650. doi:https://doi.org/10.3390/metabo11100650
- Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P, Boyle P. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122(1):155–164. doi:https://doi.org/10.1002/ijc.23033
- Warnakulasuriya S, Parkkila S, Nagao T, Preedy VR, Pasanen M, Koivisto H, Niemelä O. Demonstration of ethanol-induced protein adducts in oral leukoplakia (pre-cancer) and cancer. J Oral Pathol Med. 2007;37(3):157–165. doi:https://doi.org/10.1111/j.1600-0714.2007.00605.x
- Misztal CI, Green C, Mei C, Bhatia R, Velez Torres JM, Kamrava B, Moon S, Nicolli E, Weed D, Sargi Z, et al. Molecular and cellular mechanisms of perineural invasion in oral squamous cell carcinoma: potential targets for therapeutic intervention. Cancers (Basel. 2021;13(23):6011. doi:https://doi.org/10.3390/cancers13236011
- Le Campion ACOV, Ribeiro CMB, Luiz RR, da Silva Júnior FF, Barros HCS, dos Santos KdCB, Ferreira SJ, Gonçalves LS, Ferreira SMS. Low survival rates of oral and oropharyngeal squamous cell carcinoma. Int J Dent. 2017;2017:1–7. doi:https://doi.org/10.1155/2017/5815493
- Elaiwy O, El Ansari W, AlKhalil M, Ammar A. Epidemiology and pathology of oral squamous cell carcinoma in a multi-ethnic population: Retrospective study of 154 cases over 7 years in Qatar. Ann Med Surg (Lond). 2020;60:195–200. doi:https://doi.org/10.1016/j.amsu.2020.10.029
- McGuirt WF. Panendoscopy as a screening examination for simultaneous primary tumors in head and neck cancer: a prospective sequential study and review of the literature. Laryngoscope. 1982;92(5):569–576.
- Monteiro L, Ricardo S, Delgado M, Garcez F, do Amaral B, Lopes C. Phosphorylated EGFR at tyrosine 1173 correlates with poor prognosis in oral squamous cell carcinomas. Oral Dis. 2014;20(2):178–185. doi:https://doi.org/10.1111/odi.12087
- Yanase M, Kato K, Yoshizawa K, Noguchi N, Kitahara H, Nakamura H. Prognostic value of vascular endothelial growth factors A and C in oral squamous cell carcinoma. J Oral Pathol Med. 2014;43(7):514–520. doi:https://doi.org/10.1111/jop.12167
- Silva SD, Alaoui-Jamali MA, Hier M, Soares FA, Graner E, Kowalski LP. Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN + oral squamous cell carcinoma with extranodal spread. Clin Exp Metastasis. 2014;31(3):307–316. doi:https://doi.org/10.1007/s10585-013-9629-y
- Luo SL, Xie YG, Li Z, Ma JH, Xu X. E-cadherin expression and prognosis of oral cancer: a meta-analysis. Tumor Biol. 2014;35(6):5533–5537. doi:https://doi.org/10.1007/s13277-014-1728-0
- Li HX, Zheng JH, Fan HX, Li HP, Gao ZX, Chen D. Expression of αvβ6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications. J Oral Pathol Med. 2013;42(7):547–556. doi:https://doi.org/10.1111/jop.12044
- Liu S, Liu L, Ye W, Ye D, Wang T, Guo W, Liao Y, Xu D, Song H, Zhang L, et al. High vimentin expression associated with lymph node metastasis and predicated a poor prognosis in oral squamous cell carcinoma. Sci Rep. 2016;6:38834. doi:https://doi.org/10.1038/srep38834
- Sasahira T, Kirita T, Kuniyasu H. Update of molecular pathobiology in oral cancer: a review. Int J Clin Oncol. 2014;19(3):431–436. doi:https://doi.org/10.1007/s10147-014-0684-4
- Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101–108. doi:https://doi.org/10.1038/nature11233
- Ghahramani Almanghadim H, Ghorbian S, Khademi NS, Soleymani Sadrabadi M, Jarrahi E, Nourollahzadeh Z, Dastani M, Shirvaliloo M, Sheervalilou R, Sargazi S, et al. New insights into the importance of long non-coding RNAs in lung cancer: future clinical approaches. DNA Cell Biol. 2021;40(12):1476–1494. doi:https://doi.org/10.1089/dna.2021.0563
- Moran VA, Perera RJ, Khalil AM. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012;40(14):6391–6400. doi:https://doi.org/10.1093/nar/gks296
- Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38. doi:https://doi.org/10.1186/1476-4598-10-38
- Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-Lail R, Hochberg A, Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS One. 2007;2(9):e845. doi:https://doi.org/10.1371/journal.pone.0000845
- Calin GA, Liu C-g, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007;12(3):215–229. doi:https://doi.org/10.1016/j.ccr.2007.07.027
- Nishiyama K, Maruyama R, Niinuma T, Kai M, Kitajima H, Toyota M, Hatanaka Y, Igarashi T, Kobayashi J-I, Ogi K, et al. Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1. Cell Death Dis. 2018;9(8):826. doi:https://doi.org/10.1038/s41419-018-0893-2
- Tang J, Fang X, Chen J, Zhang H, Tang Z. Long non-coding RNA (lncRNA) in oral squamous cell carcinoma: biological function and clinical application. Cancers (Basel). 2021;13(23):5944. doi:https://doi.org/10.3390/cancers13235944
- Ziegler C, Graf J, Faderl S, Schedlbauer J, Strieder N, Förstl B, Spang R, Bruckmann A, Merkl R, Hombach S, et al. The long non-coding RNA LINC00941 and SPRR5 are novel regulators of human epidermal homeostasis. EMBO Rep. 2019;20(2):e46612(1–13). doi:https://doi.org/10.15252/embr.201846612
- Luo C, Tao Y, Zhang Y, Zhu Y, Minyao DN, Haleem M, Dong C, Zhang L, Zhang X, Zhao J, et al. Regulatory network analysis of high expressed long non-coding RNA LINC00941 in gastric cancer. Gene. 2018;662:103–109. doi:https://doi.org/10.1016/j.gene.2018.04.023
- Liu H, Wu N, Zhang Z, Zhong XDan, Zhang H, Guo H, Nie Y, Liu Y. Long non-coding RNA LIN. C00941 as a potential biomarker promotes the proliferation and metastasis of gastric cancer. Front Genet. 2019;10(5):5.
- Yan X, Zhang D, Wu W, Wu S, Qian J, Hao Y, Yan F, Zhu P, Wu J, Huang G, et al. Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and miR-34a. Cancer Res. 2017;77(23):6704–6716. doi:https://doi.org/10.1158/0008-5472.CAN-17-1915
- Wang L, Zhao H, Xu Y, Li J, Deng C, Deng Y, Bai J, Li X, Xiao Y, Zhang Y, et al. Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma. Int J Cancer. 2019;144(7):1723–1734. doi:https://doi.org/10.1002/ijc.31865
- Ai Y, Wu S, Zou C, Wei H. LINC00941 promotes oral squamous cell carcinoma progression via activating CAPRIN2 and canonical WNT/β-catenin signaling pathway. J Cell Mol Med. 2020;24(18):10512–10524. doi:https://doi.org/10.1111/jcmm.15667
- Gao T, Liu X, He B, Nie Z, Zhu C, Zhang P, Wang S. Exosomal lncRNA 91H is associated with poor development in colorectal cancer by modifying HNRNPK expression. Cancer Cell Int. 2018;18(1):11. doi:https://doi.org/10.1186/s12935-018-0506-2
- Xu L, Zhang T, Huang W, Liu X, Lu J, Gao X, Zhang Y-F, Liu L. YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth. Acta Biochim Biophys Sin (Shanghai). 2019;51(7):677–687. doi:https://doi.org/10.1093/abbs/gmz053
- Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47–62. doi:https://doi.org/10.1038/nrg.2015.10
- Lee WJ, Shin CH, Ji H, Jeong SD, Park M-S, Won H-H, Pandey PR, Tsitsipatis D, Gorospe M, Kim HH, et al. hnRNPK-regulated LINC00263 promotes malignant phenotypes through miR-147a/CAPN2. Cell Death Dis. 2021;12(4):290. doi:https://doi.org/10.1038/s41419-021-03575-1
- Xu Y, Wu W, Han Q, Wang Y, Li C, Zhang P, Xu H. New insights into the interplay between non-coding RNAs and RNA-binding protein hnrnpk in regulating cellular functions. Cells. 2019;8(1):62. doi:https://doi.org/10.3390/cells8010062
- Vermorken JB, Trigo J, Hitt R, Koralewski P, Diaz-Rubio E, Rolland F, Knecht R, Amellal N, Schueler A, Baselga J, et al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol. 2007;25(16):2171–2177. doi:https://doi.org/10.1200/JCO.2006.06.7447
- Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren X, Wei F, Yu W, Liu T, Wang X, et al. Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma. Int J Oncol. 2015;46(6):2586–2594. doi:https://doi.org/10.3892/ijo.2015.2976
- Lu M-Y, Liao Y-W, Chen P-Y, Hsieh P-L, Fang C-Y, Wu C-Y, Yen M-L, Peng B-Y, Wang DP, Cheng H-C, et al. Targeting LncRNA HOTAIR suppresses cancer stemness and metastasis in oral carcinomas stem cells through modulation of EMT. Oncotarget. 2017;8(58):98542–98552. doi:https://doi.org/10.18632/oncotarget.21614
- Gugnoni M, Ciarrocchi A. Long noncoding RNA and epithelial mesenchymal transition in cancer. Int J Mol Sci. 2019;20(8):1924(1–25).
- Li Y, Liu K, Ke Y, Zeng Y, Chen M, Li W, Liu W, Hua X, Li Z, Zhong Y, et al. Risk factors analysis of pathologically confirmed cervical lymph nodes metastasis in oral squamous cell carcinoma patients with clinically negative cervical lymph node: results from a cancer center of Central China. J Cancer. 2019;10(13):3062–3069. doi:https://doi.org/10.7150/jca.30502
- Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol. 2007;213(2):374–383. doi:https://doi.org/10.1002/jcp.21223
- MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17(1):9–26. doi:https://doi.org/10.1016/j.devcel.2009.06.016
- Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg. 2000;87(8):992–1005. doi:https://doi.org/10.1046/j.1365-2168.2000.01513.x
- Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142(3):409–419. doi:https://doi.org/10.1016/j.cell.2010.06.040
- Zhang Z, Zhou C, Chang Y, Zhang Z, Hu Y, Zhang F, Lu Y, Zheng L, Zhang W, Li X, et al. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer. Cancer Lett. 2016;376(1):62–73. doi:https://doi.org/10.1016/j.canlet.2016.03.022
- Bomsztyk K, Denisenko O, Ostrowski J. hnRNP K: one protein multiple processes. Bioessays. 2004;26(6):629–638. doi:https://doi.org/10.1002/bies.20048